Emerging Role of Semaphorins as Major Regulatory Signals and Potential Therapeutic Targets in Cancer

Cancer Cell

Volumn 22, Issue 2, 2012, Pages 145-152

  Tamagnone, Luca ^a,b  

^a CANDIOLO CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2; PLEXIN; SCATTER FACTOR RECEPTOR; SEMAPHORIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; CANCER GROWTH; CANCER INVASION; CANCER THERAPY; CELL MIGRATION; HUMAN; IN VIVO STUDY; METASTASIS; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VALIDATION PROCESS;

EID: 84865137629     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2012.06.031     Document Type: Review

References (86)

1. Appleton B.A., Wu P., Maloney J., Yin J., Liang W.C., Stawicki S., Mortara K., Bowman K.K., Elliott J.M., Desmarais W., et al. Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding. EMBO J. 2007, 26:4902-4912.
2. Argast G.M., Croy C.H., Couts K.L., Zhang Z., Litman E., Chan D.C., Ahn N.G. Plexin B1 is repressed by oncogenic B-Raf signaling and functions as a tumor suppressor in melanoma cells. Oncogene 2009, 28:2697-2709.
3. Artigiani S., Conrotto P., Fazzari P., Gilestro G.F., Barberis D., Giordano S., Comoglio P.M., Tamagnone L. Plexin-B3 is a functional receptor for semaphorin 5A. EMBO Rep. 2004, 5:710-714.
4. Balakrishnan A., Penachioni J.Y., Lamba S., Bleeker F.E., Zanon C., Rodolfo M., Vallacchi V., Scarpa A., Felicioni L., Buck M., et al. Molecular profiling of the " plexinome" in melanoma and pancreatic cancer. Hum. Mutat. 2009, 30:1167-1174.
5. Basile J.R., Castilho R.M., Williams V.P., Gutkind J.S. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc. Natl. Acad. Sci. USA 2006, 103:9017-9022.
6. Bellon A., Luchino J., Haigh K., Rougon G., Haigh J., Chauvet S., Mann F. VEGFR2 (KDR/Flk1) signaling mediates axon growth in response to semaphorin 3E in the developing brain. Neuron 2010, 66:205-219.
7. Bielenberg D.R., Hida Y., Shimizu A., Kaipainen A., Kreuter M., Kim C.C., Klagsbrun M. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J. Clin. Invest. 2004, 114:1260-1271.
8. Binmadi N.O., Yang Y.H., Zhou H., Proia P., Lin Y.L., De Paula A.M., Guimarães A.L., Poswar F.O., Sundararajan D., Basile J.R. Plexin-B1 and semaphorin 4D cooperate to promote perineural invasion in a RhoA/ROK-dependent manner. Am. J. Pathol. 2012, 180:1232-1242.
9. Capparuccia L., Tamagnone L. Semaphorin signaling in cancer cells and in cells of the tumor microenvironment-two sides of a coin. J. Cell Sci. 2009, 122:1723-1736.
10. Carmeliet P., Jain R.K. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011, 473:298-307.
11. Casazza A., Finisguerra V., Capparuccia L., Camperi A., Swiercz J.M., Rizzolio S., Rolny C., Christensen C., Bertotti A., Sarotto I., et al. Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice. J. Clin. Invest. 2010, 120:2684-2698.
12. Casazza A., Fu X., Johansson I., Capparuccia L., Andersson F., Giustacchini A., Squadrito M.L., Venneri M.A., Mazzone M., Larsson E., Carmeliet P., De P.M., Naldini L., Tamagnone L., Rolny C. Systemic and targeted delivery of semaphorin 3a inhibits tumor angiogenesis and progression in mouse tumor models. Arterioscler Thromb Vasc Biol. 2011, 31:741-749.
13. Casazza A., Kigel B., Maione F., Capparuccia L., Kessler O., Giraudo E., Mazzone M., Neufeld G., Tamagnone L. Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform. EMBO Mol Med 2012, 4:234-250.
14. Castellani V., De Angelis E., Kenwrick S., Rougon G. Cis and trans interactions of L1 with neuropilin-1 control axonal responses to semaphorin 3A. EMBO J. 2002, 21:6348-6357.
15. Catalano A., Caprari P., Moretti S., Faronato M., Tamagnone L., Procopio A. Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function. Blood 2006, 107:3321-3329.
16. Caunt M., Mak J., Liang W.C., Stawicki S., Pan Q., Tong R.K., Kowalski J., Ho C., Reslan H.B., Ross J., et al. Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 2008, 13:331-342.
17. Chakraborty G., Kumar S., Mishra R., Patil T.V., Kundu G.C. Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model. PLoS ONE 2012, 7:e33633.
18. Clarhaut J., Gemmill R.M., Potiron V.A., Ait-Si-Ali S., Imbert J., Drabkin H.A., Roche J. ZEB-1, a repressor of the semaphorin 3F tumor suppressor gene in lung cancer cells. Neoplasia 2009, 11:157-166.
19. Coma S., Shimizu A., Klagsbrun M. Hypoxia induces tumor and endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor neuropilin 2. Cell Adhes. Migr. 2011, 5:266-275.
20. Dallas N.A., Gray M.J., Xia L., Fan F., van Buren G., Gaur P., Samuel S., Lim S.J., Arumugam T., Ramachandran V., et al. Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma. Clin. Cancer Res. 2008, 14:8052-8060.
21. Fazzari P., Penachioni J., Gianola S., Rossi F., Eickholt B.J., Maina F., Alexopoulou L., Sottile A., Comoglio P.M., Flavell R.A., Tamagnone L. Plexin-B1 plays a redundant role during mouse development and in tumour angiogenesis. BMC Dev. Biol. 2007, 7:55.
22. Franco M., Tamagnone L. Tyrosine phosphorylation in semaphorin signalling: shifting into overdrive. EMBO Rep. 2008, 9:865-871.
23. Fukushima Y., Okada M., Kataoka H., Hirashima M., Yoshida Y., Mann F., Gomi F., Nishida K., Nishikawa S., Uemura A. Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice. J. Clin. Invest. 2011, 121:1974-1985.
24. Giordano S., Corso S., Conrotto P., Artigiani S., Gilestro G., Barberis D., Tamagnone L., Comoglio P.M. The semaphorin 4D receptor controls invasive growth by coupling with Met. Nat. Cell Biol. 2002, 4:720-724.
25. Gu C., Yoshida Y., Livet J., Reimert D.V., Mann F., Merte J., Henderson C.E., Jessell T.M., Kolodkin A.L., Ginty D.D. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 2005, 307:265-268.
26. Hayashi M., Nakashima T., Taniguchi M., Kodama T., Kumanogoh A., Takayanagi H. Osteoprotection by semaphorin 3A. Nature 2012, 485:69-74.
27. Holmes S., Downs A.M., Fosberry A., Hayes P.D., Michalovich D., Murdoch P., Moores K., Fox J., Deen K., Pettman G., et al. Sema7A is a potent monocyte stimulator. Scand. J. Immunol. 2002, 56:270-275.
28. Janssen B.J., Robinson R.A., Pérez-Brangulí F., Bell C.H., Mitchell K.J., Siebold C., Jones E.Y. Structural basis of semaphorin-plexin signalling. Nature 2010, 467:1118-1122.
29. Kärpänen T., Heckman C.A., Keskitalo S., Jeltsch M., Ollila H., Neufeld G., Tamagnone L., Alitalo K. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J. 2006, 20:1462-1472.
30. Kessler O., Shraga-Heled N., Lange T., Gutmann-Raviv N., Sabo E., Baruch L., Machluf M., Neufeld G. Semaphorin-3F is an inhibitor of tumor angiogenesis. Cancer Res. 2004, 64:1008-1015.
31. Kigel B., Rabinowicz N., Varshavsky A., Kessler O., Neufeld G. Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling. Blood 2011, 118:4285-4296.
32. Kolodkin A.L., Matthes D.J., Goodman C.S. The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 1993, 75:1389-1399.
33. Kruger R.P., Aurandt J., Guan K.L. Semaphorins command cells to move. Nat. Rev. Mol. Cell Biol. 2005, 6:789-800.
34. Kumanogoh A., Watanabe C., Lee I., Wang X., Shi W., Araki H., Hirata H., Iwahori K., Uchida J., Yasui T., et al. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. Immunity 2000, 13:621-631.
35. Kumanogoh A., Marukawa S., Suzuki K., Takegahara N., Watanabe C., Ch'ng E., Ishida I., Fujimura H., Sakoda S., Yoshida K., Kikutani H. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature 2002, 419:629-633.
36. Lepelletier Y., Moura I.C., Hadj-Slimane R., Renand A., Fiorentino S., Baude C., Shirvan A., Barzilai A., Hermine O. Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization. Eur. J. Immunol. 2006, 36:1782-1793.
37. Li X., Law J.W., Lee A.Y. Semaphorin 5A and plexin-B3 regulate human glioma cell motility and morphology through Rac1 and the actin cytoskeleton. Oncogene 2012, 31:595-610.
38. Liu H., Juo Z.S., Shim A.H., Focia P.J., Chen X., Garcia K.C., He X. Structural basis of semaphorin-plexin recognition and viral mimicry from Sema7A and A39R complexes with PlexinC1. Cell 2010, 142:749-761.
39. Maione F., Molla F., Meda C., Latini R., Zentilin L., Giacca M., Seano G., Serini G., Bussolino F., Giraudo E. Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models. J. Clin. Invest. 2009, 119:3356-3372.
40. Maione F., Capano S., Regano D., Zentilin L., Giacca M., Casanovas O., Bussolino F., Serini G., Giraudo E. Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice. J. Clin. Invest. 2012, 122:1832-1848.
41. Meda C., Molla F., De Pizzol M., Regano D., Maione F., Capano S., Locati M., Mantovani A., Latini R., Bussolino F., Giraudo E. Semaphorin 4A exerts a proangiogenic effect by enhancing vascular endothelial growth factor-A expression in macrophages. J. Immunol. 2012, 188:4081-4092.
42. Miao H.Q., Soker S., Feiner L., Alonso J.L., Raper J.A., Klagsbrun M. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J. Cell Biol. 1999, 146:233-242.
43. Moriya J., Minamino T., Tateno K., Okada S., Uemura A., Shimizu I., Yokoyama M., Nojima A., Okada M., Koga H., Komuro I. Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis. Circ. Res. 2010, 106:391-398.
44. Negishi-Koga T., Shinohara M., Komatsu N., Bito H., Kodama T., Friedel R.H., Takayanagi H. Suppression of bone formation by osteoclastic expression of semaphorin 4D. Nat. Med. 2011, 17:1473-1480.
45. Neufeld G., Kessler O. The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat. Rev. Cancer 2008, 8:632-645.
46. Neufeld G., Sabag A.D., Rabinovicz N., Kessler O. Semaphorins in angiogenesis and tumor progression. Cold Spring Harb Perspect Med. 2012, 2:a006718.
47. Nogi T., Yasui N., Mihara E., Matsunaga Y., Noda M., Yamashita N., Toyofuku T., Uchiyama S., Goshima Y., Kumanogoh A., Takagi J. Structural basis for semaphorin signalling through the plexin receptor. Nature 2010, 467:1123-1127.
48. Oinuma I., Ishikawa Y., Katoh H., Negishi M. The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras. Science 2004, 305:862-865.
49. Pan G.Q., Ren H.Z., Zhang S.F., Wang X.M., Wen J.F. Expression of semaphorin 5A and its receptor plexin B3 contributes to invasion and metastasis of gastric carcinoma. World J. Gastroenterol. 2009, 15:2800-2804.
50. Pasterkamp R.J., Peschon J.J., Spriggs M.K., Kolodkin A.L. Semaphorin 7A promotes axon outgrowth through integrins and MAPKs. Nature 2003, 424:398-405.
51. Qiang R., Wang F., Shi L.Y., Liu M., Chen S., Wan H.Y., Li Y.X., Li X., Gao S.Y., Sun B.C., Tang H. Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells. Int. J. Biochem. Cell Biol. 2011, 43:632-641.
52. Rizzolio S., Tamagnone L. Multifaceted role of neuropilins in cancer. Curr. Med. Chem. 2011, 18:3563-3575.
53. Rody A., Karn T., Ruckhäberle E., Hanker L., Metzler D., Müller V., Solbach C., Ahr A., Gätje R., Holtrich U., Kaufmann M. Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers-results of a large scale microarray analysis. Eur. J. Cancer 2009, 45:405-413.
54. Roodink I., Raats J., van der Zwaag B., Verrijp K., Kusters B., van Bokhoven H., Linkels M., de Waal R.M., Leenders W.P. Plexin D1 expression is induced on tumor vasculature and tumor cells: a novel target for diagnosis and therapy?. Cancer Res. 2005, 65:8317-8323.
55. Sadanandam A., Varney M.L., Singh S., Ashour A.E., Moniaux N., Deb S., Lele S.M., Batra S.K., Singh R.K. High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis. Int. J. Cancer 2010, 127:1373-1383.
56. Sakurai A., Gavard J., Annas-Linhares Y., Basile J.R., Amornphimoltham P., Palmby T.R., Yagi H., Zhang F., Randazzo P.A., Li X., et al. Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras. Mol. Cell. Biol. 2010, 30:3086-3098.
57. Sakurai A., Jian X., Lee C.J., Manavski Y., Chavakis E., Donaldson J., Randazzo P.A., Gutkind J.S. Phosphatidylinositol-4-phosphate 5-kinase and GEP100/Brag2 protein mediate antiangiogenic signaling by semaphorin 3E-plexin-D1 through Arf6 protein. J. Biol. Chem. 2011, 286:34335-34345.
58. Unified nomenclature for the semaphorins/collapsins. Cell 1999, 97:551-552. Semaphorin Nomenclature Committee.
59. Semenza G.L. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol. Sci. 2012, 33:207-214.
60. Serini G., Valdembri D., Zanivan S., Morterra G., Burkhardt C., Caccavari F., Zammataro L., Primo L., Tamagnone L., Logan M., et al. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 2003, 424:391-397.
61. Sierra J.R., Corso S., Caione L., Cepero V., Conrotto P., Cignetti A., Piacibello W., Kumanogoh A., Kikutani H., Comoglio P.M., et al. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J. Exp. Med. 2008, 205:1673-1685.
62. Smith E.P., Shanks K., Lipsky M.M., DeTolla L.J., Keegan A.D., Chapoval S.P. Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor. BMC Immunol. 2011, 12:30.
63. Stevens L., McClelland L., Fricke A., Williamson M., Kuo I., Scott G. Plexin B1 suppresses c-Met in melanoma: a role for plexin B1 as a tumor-suppressor protein through regulation of c-Met. J. Invest. Dermatol. 2010, 130:1636-1645.
64. Sun Q., Zhou H., Binmadi N.O., Basile J.R. Hypoxia-inducible factor-1-mediated regulation of semaphorin 4D affects tumor growth and vascularity. J. Biol. Chem. 2009, 284:32066-32074.
65. Suzuki K., Okuno T., Yamamoto M., Pasterkamp R.J., Takegahara N., Takamatsu H., Kitao T., Takagi J., Rennert P.D., Kolodkin A.L., et al. Semaphorin 7A initiates T-cell-mediated inflammatory responses through alpha1beta1 integrin. Nature 2007, 446:680-684.
66. Swiercz J.M., Kuner R., Offermanns S. Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2. J. Cell Biol. 2004, 165:869-880.
67. Swiercz J.M., Worzfeld T., Offermanns S. ErbB-2 and met reciprocally regulate cellular signaling via plexin-B1. J. Biol. Chem. 2008, 283:1893-1901.
68. Takahashi T., Fournier A., Nakamura F., Wang L.H., Murakami Y., Kalb R.G., Fujisawa H., Strittmatter S.M. Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 1999, 99:59-69.
69. Takamatsu H., Kumanogoh A. Diverse roles for semaphorin-plexin signaling in the immune system. Trends Immunol. 2012, 33:127-135.
70. Takegahara N., Takamatsu H., Toyofuku T., Tsujimura T., Okuno T., Yukawa K., Mizui M., Yamamoto M., Prasad D.V., Suzuki K., et al. Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat. Cell Biol. 2006, 8:615-622.
71. Tamagnone L., Comoglio P.M. Signalling by semaphorin receptors: cell guidance and beyond. Trends Cell Biol. 2000, 10:377-383.
72. Tamagnone L., Mazzone M. Semaphorin signals on the road of endothelial tip cells. Dev. Cell 2011, 21:189-190.
73. Tamagnone L., Artigiani S., Chen H., He Z., Ming G.I., Song H., Chedotal A., Winberg M.L., Goodman C.S., Poo M., et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell 1999, 99:71-80.
74. Tran T.S., Kolodkin A.L., Bharadwaj R. Semaphorin regulation of cellular morphology. Annu. Rev. Cell Dev. Biol. 2007, 23:263-292.
75. Tseng C.H., Murray K.D., Jou M.F., Hsu S.M., Cheng H.J., Huang P.H. Sema3E/plexin-D1 mediated epithelial-to-mesenchymal transition in ovarian endometrioid cancer. PLoS ONE 2011, 6:e19396.
76. Urbich C., Kaluza D., Frömel T., Knau A., Bennewitz K., Boon R.A., Bonauer A., Doebele C., Boeckel J.N., Hergenreider E., et al. MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. Blood 2012, 119:1607-1616.
77. Valente G., Nicotra G., Arrondini M., Castino R., Capparuccia L., Prat M., Kerim S., Tamagnone L., Isidoro C. Co-expression of plexin-B1 and Met in human breast and ovary tumours enhances the risk of progression. Cell. Oncol. 2009, 31:423-436.
78. Wang Y., He H., Srivastava N., Vikarunnessa S., Chen Y.B., Jiang J., Cowan C.W., Zhang X. Plexins are GTPase-activating proteins for Rap and are activated by induced dimerization. Sci. Signal. 2012, 5:ra6.
79. Wen H., Lei Y., Eun S.Y., Ting J.P. Plexin-A4-semaphorin 3A signaling is required for Toll-like receptor- and sepsis-induced cytokine storm. J. Exp. Med. 2010, 207:2943-2957.
80. Wong O.G., Nitkunan T., Oinuma I., Zhou C., Blanc V., Brown R.S., Bott S.R., Nariculam J., Box G., Munson P., et al. Plexin-B1 mutations in prostate cancer. Proc. Natl. Acad. Sci. USA 2007, 104:19040-19045.
81. Worzfeld T., Swiercz J.M., Looso M., Straub B.K., Sivaraj K.K., Offermanns S. ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis. J. Clin. Invest. 2012, 122:1296-1305.
82. Yamamoto M., Suzuki K., Okuno T., Ogata T., Takegahara N., Takamatsu H., Mizui M., Taniguchi M., Chédotal A., Suto F., et al. Plexin-A4 negatively regulates T lymphocyte responses. Int. Immunol. 2008, 20:413-420.
83. Yang T., Terman J.R. 14-3-3ε couples protein kinase A to semaphorin signaling and silences plexin RasGAP-mediated axonal repulsion. Neuron 2012, 74:108-121.
84. Ye S., Hao X., Zhou T., Wu M., Wei J., Wang Y., Zhou L., Jiang X., Ji L., Chen Y., et al. Plexin-B1 silencing inhibits ovarian cancer cell migration and invasion. BMC Cancer 2010, 10:611.
85. Zhou Y., Gunput R.A., Pasterkamp R.J. Semaphorin signaling: progress made and promises ahead. Trends Biochem. Sci. 2008, 33:161-170.
86. Zhu L., Bergmeier W., Wu J., Jiang H., Stalker T.J., Cieslak M., Fan R., Boumsell L., Kumanogoh A., Kikutani H., et al. Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proc. Natl. Acad. Sci. USA 2007, 104:1621-1626.